Market Overview:
Ephedrine is a medication and stimulant. It is used to treat low blood pressure, chest pain, and other conditions. It is also used as a recreational drug for its stimulant effects. Ephedrine occurs naturally in the leaves of the Ephedra plant.
Product Definition:
Ephedrine is a stimulant drug that is used to treat breathing problems, like asthma and bronchitis. It can also be used to prevent low blood pressure during surgery.
Tablet:
Tablet is a form of oral dosage medication, which is made up of solid or liquid fillings and is administered in the mouth. It can be used for the treatment of bronchitis, asthma, congestive heart failure and other such conditions. The drug works by increasing blood flow to the lungs thereby enabling breathing. In addition it reduces swelling in the airways which enables cough to produce less mucus thus providing relief from congestion.
Capsule:
Capsule is a small package containing drug substance and its delivery system. The size of capsule depends on the type of drug it contains. Capsules are available in different sizes such as multi-layer, film, enteric coated, and liquid filled capsules. They help protect the formulation from light exposure which helps maintain the potency of drugs for a longer time period.
Application Insights:
The other uses segment held around 60.0% of the global market share in terms of revenue in 2017. The recreational use of ephedrine is more prevalent among users from North America and Europe regions. These two regions together hold close to 75% of the global market share for ephedrine consumption for recreational purposes only. Ephedra contains compounds that act as stimulants which increase metabolism, brain activity and reduce fat deposition when taken in low doses; however, high doses can lead to adverse effects such as hypertension and heart attack due to its sympathomimetic properties (Al-Sabee et al., 2016).
Medical use is expected to be the fastest-growing application segment over the forecast period owing to increasing usage as an asthma inhaler alternative or weight loss supplement by medical practitioners worldwide (Al-Sabee et al., 2016).
Regional Analysis:
Asia Pacific dominated the global ephedrine market in 2016. The region is expected to continue its dominance over the forecast period owing to rising demand for medicines and other products, such as dietary supplements. China is one of the largest producers of ephedrine and has reduced its production significantly in recent years, which has resulted in a significant increase in prices since 2015. Moreover, India also produces large amounts of this chemical but exports most of it due to regulatory restrictions on use within India.
North America accounted for a major share owing to high consumption rates among users regarding both medical and non-medical purposes coupled with stringent government regulations that have restricted manufacturing methods used by manufacturers thus increasing product costs considerably over past few years. Ephedrine was once widely available without prescription OTC; however, current U.S.
Growth Factors:
- Increasing demand for weight loss and sports nutrition supplements
- Rising prevalence of lifestyle diseases such as obesity and diabetes
- Growing popularity of energy drinks and other ephedrine-based beverages
- Proliferation of online retail channels that offer a wide variety of ephedrine products
- increasing research on the therapeutic potentials of ephedrine
Scope Of The Report
Report Attributes
Report Details
Report Title
Ephedrine Market Research Report
By Type
Tablet, Capsule, Injection
By Application
Medical use, Recreational use, Other uses
By Companies
Pfizer, Servier, Roche, Merck, Amgen, Novartis, Sanofi, Medarex, Malladi Drugs?Pharmaceuticals, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Ephedrine Market Report Segments:
The global Ephedrine market is segmented on the basis of:
Types
Tablet, Capsule, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical use, Recreational use, Other uses
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Servier
- Roche
- Merck
- Amgen
- Novartis
- Sanofi
- Medarex
- Malladi Drugs?Pharmaceuticals
- GlaxoSmithKline
Highlights of The Ephedrine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Capsule
- Injection
- By Application:
- Medical use
- Recreational use
- Other uses
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ephedrine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ephedrine is a medication used to treat asthma and other breathing problems. It works by widening the airways and helping the body to breathe more easily.
Some of the key players operating in the ephedrine market are Pfizer, Servier, Roche, Merck, Amgen, Novartis, Sanofi, Medarex, Malladi Drugs?Pharmaceuticals, GlaxoSmithKline.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ephedrine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ephedrine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ephedrine Market - Supply Chain
4.5. Global Ephedrine Market Forecast
4.5.1. Ephedrine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ephedrine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ephedrine Market Absolute $ Opportunity
5. Global Ephedrine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ephedrine Market Size and Volume Forecast by Type
5.3.1. Tablet
5.3.2. Capsule
5.3.3. Injection
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ephedrine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ephedrine Market Size and Volume Forecast by Application
6.3.1. Medical use
6.3.2. Recreational use
6.3.3. Other uses
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ephedrine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ephedrine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ephedrine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ephedrine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ephedrine Demand Share Forecast, 2019-2026
9. North America Ephedrine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ephedrine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ephedrine Market Size and Volume Forecast by Application
9.4.1. Medical use
9.4.2. Recreational use
9.4.3. Other uses
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ephedrine Market Size and Volume Forecast by Type
9.7.1. Tablet
9.7.2. Capsule
9.7.3. Injection
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ephedrine Demand Share Forecast, 2019-2026
10. Latin America Ephedrine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ephedrine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ephedrine Market Size and Volume Forecast by Application
10.4.1. Medical use
10.4.2. Recreational use
10.4.3. Other uses
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ephedrine Market Size and Volume Forecast by Type
10.7.1. Tablet
10.7.2. Capsule
10.7.3. Injection
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ephedrine Demand Share Forecast, 2019-2026
11. Europe Ephedrine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ephedrine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ephedrine Market Size and Volume Forecast by Application
11.4.1. Medical use
11.4.2. Recreational use
11.4.3. Other uses
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ephedrine Market Size and Volume Forecast by Type
11.7.1. Tablet
11.7.2. Capsule
11.7.3. Injection
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. ByCountry
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ephedrine Demand Share, 2019-2026
12. Asia Pacific Ephedrine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ephedrine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ephedrine Market Size and Volume Forecast by Application
12.4.1. Medical use
12.4.2. Recreational use
12.4.3. Other uses
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ephedrine Market Size and Volume Forecast by Type
12.7.1. Tablet
12.7.2. Capsule
12.7.3. Injection
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ephedrine Demand Share, 2019-2026
13. Middle East & Africa Ephedrine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ephedrine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ephedrine Market Size and Volume Forecast by Application
13.4.1. Medical use
13.4.2. Recreational use
13.4.3. Other uses
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ephedrine Market Size and Volume Forecast by Type
13.7.1. Tablet
13.7.2. Capsule
13.7.3. Injection
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ephedrine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ephedrine Market: Market Share Analysis
14.2. Ephedrine Distributors and Customers
14.3. Ephedrine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Servier
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Amgen
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Novartis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sanofi
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Medarex
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Malladi Drugs?Pharmaceuticals
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. GlaxoSmithKline
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
